Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

2021 · doi:10.1101/2021.12.14.21267615

preprint OA: gold CC-BY-NC-ND-4.0

📄 Open PDF View at publisher

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate 2021

Cited by (1)

Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate 2021

Source provenance

europepmc: last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall: last seen: 2026-05-21T05:10:58.409756+00:00

License: CC-BY-NC-ND-4.0